NTRK1-fusion as an acquired resistance mechanism in EGFRex19 mutated NSCLC: a case report by Jielin Li, Yunyun Shi, Mengge Zheng, Chenkang Yang, Hong Gao, Xiaoling Li

Subjects: “…EGFR-mutated NSCLC…”
Get full text

New therapeutic approaches for EGFR mutated non-small cell lung cancer on osimertinib era by Jaime Rubio-Perez, Roberto Hernandez, Carlota Santolaya, Maria Cruz Martin-Soberon, Sandra Zazo, Nerea Carvajal, Federico Rojo

Subjects: “…EGFR-mutated NSCLC…”
Get full text

Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms by Arianna Marinello, MD, Claudia Parisi, MD, Damien Vasseur, PhD, David Combarel, PharmD, Juliette Bihoreau, NP, Pernelle Lavaud, MD, Rémy Ezzedine, MD, Lodovica Zullo, MD, Luc Friboulet, PhD, Gerard Zalcman, MD, PhD, Antoine Italiano, MD, PhD, Benjamin Besse, MD, PhD, Mihaela Aldea, MD, PhD

Subjects: “…EGFR-mutated NSCLC…”
Get full text

A Podcast Discussion on the Intracranial Efficacy of Antibody–Drug Conjugates in Patients with EGFR-Mutated NSCLC with Brain Metastases by Melissa L. Johnson, Jessica J. Lin, Adrienne Boire, Melin J. Khandekar, Helena A. Yu

Subjects: Get full text

Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer by Esraa A. Abdelsalam, Amer Ali Abd El-Hafeez, Wagdy M. Eldehna, Mahmoud A. El Hassab, Hala Mohamed M. Marzouk, Mahmoud M. Elaasser, Nageh A. Abou Taleb, Kamilia M. Amin, Hatem A. Abdel-Aziz, Pradipta Ghosh, Sherif F. Hammad

Subjects: Get full text

Chromosomal Instability Is Associated with cGAS–STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer by Kimio Yonesaka, Takashi Kurosaki, Junko Tanizaki, Hisato Kawakami, Kaoru Tanaka, Osamu Maenishi, Shiki Takamura, Kazuko Sakai, Yasutaka Chiba, Takeshi Teramura, Hiroki Goto, Eri Otsuka, Hiroaki Okida, Masanori Funabashi, Yuuri Hashimoto, Kenji Hirotani, Yasuki Kamai, Takashi Kagari, Kazuto Nishio, Kazuhiro Kakimi, Hidetoshi Hayashi

Subjects: “…EGFR-mutated non-small-cell lung cancer…”
Get full text

Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions by Kinsley Wang, Robert Hsu

Subjects: Get full text

A Novel Exon 19 EGFR mutation in a patient with lung adenocarcinoma: A Case Report and Literature Review by Laura Gutiérrez-Sainz, Rocío Rosas-Alonso, Carlos Rodríguez-Antolín, Carmen Rodríguez-Jiménez, Isabel Esteban Rodríguez, Rafael Peláez, Oliver Higuera Gómez, Julia Villamayor, Patricia Cruz-Castellanos, Alberto Peláez-García, Inmaculada Ibáñez de Cáceres, Javier de Castro Carpeño

Subjects: Get full text

A Case Report of Lung Adenocarcinoma with EGFR G719A Mutation 
and LMNA-NTRK1 Fusion by Shiqi SONG, Yaxian YANG, Weiquan LUO, Yueya LIANG, Qi LI, Tongxu ZHUO, Weibin XIONG, Jian HUANG

Subjects: Get full text

Clinical Management in NSCLC Patients With EGFR Mutation After Osimertinib Progression With Unknown Resistance Mechanisms by Xin Liao, Tingting He, Xiong Wan, Pian Liu, Jing Li, Yong He, Yubo Wang

Subjects: Get full text

City scale related to epidermal growth factor receptor mutations status in Chinese non-small cell lung cancer by Guang-Gui Ding, Jie-Lun Wen, Rui Gong, Jiao-Jiao Yang, Wen-Jian Cen, Ling Deng, Fang Wang, Li-Yue Sun

Subjects: Get full text

TRANS: a prediction model for EGFR mutation status in NSCLC based on radiomics and clinical features by Zhigang Chen, Huiying Lu, Ao Liu, Jia Weng, Lei Gan, Lina Zhou, Xiao Ding, Shicheng Li

Subjects: “…EGFR mutation…”
Get full text

Lung Adenocarcinoma with EGFR Exon 20 H773_V774delinsLM Mutation 
Sensitive to Furmonertinib: A Case Report by Rongzhen LI, Yan XU, Xiaoxing GAO, Minjiang CHEN, Wei ZHONG, Mengzhao WANG

Subjects: Get full text

Pulmonary Sarcomatoid Carcinoma Initially Misdiagnosed as Aspergillosis: A Diagnostic Challenge by YingYing Qian

Subjects: Get full text

High-dose furmonertinib plus bevacizumab in EGFR-mutant non-small cell lung cancer with brain metastases after resistance to third-generation EGFR-TKIs: A retrospective study by Yin Pan, Meichen Li, Mingjie Yu, Jing Chen, Hui Yu, Kaijing Liu, Likun Chen

Subjects: Get full text

BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature by Marianna Peroni, MD, Alessandro Leonetti, MD, PhD, Roberta Minari, MSc, PhD, Michela Verzè, MSc, Letizia Gnetti, MD, Lorena Bottarelli, MSc, PhD, Cinzia Azzoni, MSc, PhD, Marco Galaverni, MD, Nicola Simoni, MD, Gabriele Missale, MD, Elisabetta Biasini, MD, Marcello Tiseo, MD, PhD

Subjects: “…EGFR mutation…”
Get full text

Correlation analysis on epidermal growth factor receptor (EGFR) mutations and clinicopathological characteristics in lung adenocarcinomas by Haitao Wang, Changhua Ji, Chengjun Zhou, Hui Li

Subjects: “…EGFR mutation…”
Get full text

Comparative Survival Analysis of Anti‐Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR‐TKI Treatment: A Retrospective Cohort Study by Yi‐Tse Su, Shu‐Farn Tey, Chung‐Ta Lee, Chien‐Yu Lin, Jeng‐Shiuan Tsai, Chien‐Chung Lin, Chin‐Wei Kuo

Subjects: Get full text

Case Report: A Bilateral Synchronous Primary Non‐Small Cell Lung Cancer Patient With Two Different EGFR Mutations by Thanh‐Dung Quach, Kien Hung Do, Dinh Tung Nguyen, Hyeon‐Gyu Yi, Thi‐Phuong Vu, Tran Thanh Tin, Nghi Le Vinh, Son Hai Vu

Subjects: Get full text

Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome by Mingyuan Du, Cuiwei Liu, Leichong Chen, Zhenyu Li, Sijia Zhang, Rui Meng

Subjects: Get full text